Why the study?
Does pharmacologic antagonism of the renin-angiotensin system mitigate the adverse effects of high salt intake on blood pressure and proteinuria in patients with diabetes and hypertension?
Population
Patients with hypertension and diabetes
Design
Review
Loading...
May support RAS antagonism in salt-sensitive diabetic hypertension; leaves open prospective renal outcome trials.
Does pharmacologic antagonism of the renin-angiotensin system mitigate the adverse effects of high salt intake on blood pressure and proteinuria in patients with diabetes and hypertension?
Salt sensitivity in diabetic hypertensive patients may be related to inadequate suppression of the renin-angiotensin system, highlighting the importance of RAS antagonism in this population.
A 1998 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: